A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
Clinical trial NCT06635798 · RECRUITING
Trial details
- NCT number
- NCT06635798
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2024-12-04
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.